I'm not aware that activating a cath lab in a patient who is not having a STEMI improves long-term hard outcomes like mortality. Patients with STEMI do benefit from PCI (the sooner the better) compared with thrombolysis (its not as signifcant as you would believe however).
However, to my knowledge and based upon the evidence I have read there is no benefit for IMMEDIATE revascularization in routine patients with NSTEMI/UA even in the face of EKG changes. This doesn't mean that it never happens as multiple times i have called cardioloy with good story + EKG changes = Cath lab, I'm just saying I don't think there is good RCT showing hard end-point benefits like Mortality benefit. I also don't push to hard for them to rush them off to cath lab if they are not having a STEMI.
There is a cochrane review on this topic sort of:
Hoenig et al. Early Invasive versus conservative stretegies for unstable angina and non-ST elevation myocardial infarction in the stent era. Cochrane library 2010.
Basically showed benefit in anginal symptoms, readmission in short term, recurrent MI in long-term. No change in death on long-term follow-up, however.
if there is some newer stuff (not the GIIb/IIIa inhibitor lit in the NEJM), that is out that I'm unaware of I'd appreciate an update.